News Industry News HeartWare Completes Enrollment In ENDURANCE2 Supplemental Destination Therapy Trial August 10, 2015
News Industry News Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy June 16, 2015
Presentation TCT 2014 LVADs for Chronic Heart Failure - Lessons Learned from HMII, HVAD, Jarvik, and Others Presenter: John C Criscione, Elmir Omerovic, Bartley P. Griffith September 16, 2014
Presentation TCT 2014 Advanced Heart Failure Therapies in 2014: LVAD or Transplant? Presenter: Finn Gustafsson September 16, 2014
Presentation TCT 2013 LVAD Complications State-of-the-Art: Current Status on Thrombosis, Stokes, Bleeding and Arrhythmias Presenter: Keith Aaronson October 28, 2013
Presentation TCT 2012 Contemporary LVAD Therapy: Destination, Recovery, Bridge? Presenter: Emma Birks October 23, 2012